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Abstract
Introduction: Intramedullary spinal cord metastasis is very rare. The majority are discovered incidentally during
autopsy. Most symptomatic patients present with rapidly progressive neurological deficits and require immediate
examination. Few patients demonstrate features of Brown-Séquard syndrome. Radiotherapy is the gold-standard of
therapy for Intramedullary spinal cord metastasis. The overall prognosis is poor and the mortality rate is very high.
We present what is, to the best of our knowledge, the first case of Intramedullary spinal cord metastasis of
colorectal carcinoma presenting as Brown-Séquard syndrome.
Case presentation: We present the case of a 71-year-old Caucasian man with colonic adenocarcinoma who
developed Intramedullary spinal cord metastasis and showed features of Brown-Séquard syndrome, which is an
uncommon presentation of Intramedullary spinal cord metastasis.
Conclusion: This patient had an Intramedullary spinal cord metastasis, a rare form of metastatic disease, secondary
to colonic carcinoma. The metastasis manifested clinically as Brown-Séquard syndrome, itself a very uncommon
condition. This syndrome is rarely caused by intramedullary tumors. This unique case has particular interest in
medicine, especially for the specialties of medical, surgical and radiation oncology. We hope that it will add more
information to the literature about these entities.
Introduction
Intramedullary spinal cord metastasis (ISCM) is very
rare, accounting for only 0.9-5.0% of all spinal cord
metastases. The majority are discovered incidentally
during autopsy, and manifest clinically in only 0.1-0.4%
of cancer patients. Only 3% of pathologically confirmed
ISCM are secondary to colorectal cancer. Most sympto-
matic patients present with rapidly progressive neurolo-
gical deficits and require immediate examination. Of
these, 23% demonstrate features of Brown-Séquard syn-
drome. Radiotherapy is the gold-standard of therapy for
ISCM. The overall prognosis is poor; mortality rate is
80% during the first three to four months after the
appearance of the first symptom. We present what is, to
t h eb e s to fo u rk n o w l e d g e ,t h ef i r s tc a s eo fa nI S C Mo f
colorectal carcinoma presenting as Brown- Séquard
syndrome.
Case presentation
A 71-year-old Caucasian man was diagnosed with poorly
differentiated pT3N2M0 adenocarcinoma of the trans-
v e r s ec o l o n .H eu n d e r w e n tat r a n s v e r s ec o l e c t o m yf o l -
lowed by adjuvant chemotherapy which he could not
tolerate, and therefore stopped after three cycles. One
year later he developed a single metastasis to the left
lobe of his liver which was successfully resected. Follow-
ing the resection he tolerated 12 cycles of adjuvant che-
motherapy (irinotecan and de Gramont) and continued
in remission.
Four months after finishing chemotherapy, a surveil-
lance computed tomography (CT) scan showed a new
single liver nodule highly suspicious of metastasis.
Another surgical resection was being considered and a
positron emission tomography (PET) CT scan was per-
formed to exclude the presence of metastases elsewhere.
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(FDG) -avid pulmonary nodules were found, as well as a
small focus of intense tracer uptake in the spinal canal
at the C2-C3 level in his neck (Figures 1, 2, 3). These
findings precluded surgical resection. At that time our
patient was totally asymptomatic from a neurological
point of view.
One week later our patient started to feel pins and
needles in his right upper and lower limbs. His symp-
toms worsened rapidly over the next three days and
progressed to motor weakness. Two days later he was
unable to walk without using a stick or being supported.
There was no history of trauma and he denied any loss
of sphincteric control. He was referred and reviewed as
an emergency and admitted on the same day. A
neurological examination revealed the following signs
on his right side: spasticity, hyperreflexia (all right deep
tendon reflexes), weakness, decreased tactile discrimina-
tion, joint and vibration sense, and upgoing plantar
reflex. On his left side, the only abnormality was
decreased temperature and pain sensations below the
Figure 1 FDG PET-CT maximum intensity projection image
showing three FDG-avid pulmonary nodules.
Figure 2 Sagittal fused PET-CT scan of his cervical spine
showing a small focus of intense tracer uptake in the spinal
canal at C2-C3 level in his neck.
Figure 3 Axial fused PET-CT scan of the cervical spine showing
a small focus of intense tracer uptake in the spinal canal at
C2-C3 level in the neck.
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signs on either side. His coordination was normal.
Our patient was immediately started on intravenous
high-dose dexamethasone and an urgent magnetic reso-
nance imaging (MRI) of his cervical spine was per-
formed that day. The scan showed an oblong expansile
intramedullary lesion at the C2/C3 level of the spinal
cord, associated with a large proximal and distal syrinx
and edema extending from the cervico-medullary junc-
tion to the inferior aspect of his T3 vertebral body. The
lesion enhanced post-contrast and measured about 2 cm
in cranio-caudal dimension. It was slightly to the right
of the midline. There was no evidence of bone involve-
ment (Figure 4, 5, 6).
Surgical resection of this intramedullary lesion was not
an option in the presence of other lesions in the liver
and the lungs, and therefore our patient was referred for
palliative radiotherapy.
Discussion
Spinal cord tumors are either extramedullary or intra-
medullary. The latter are less common and they form
only 5-10% of cases, a minority of which are due to
metastases. Of 1096 carcinoma patients studied prospec-
tively at autopsy by Chason et al., metastases to the cen-
tral nervous system (CNS) were found in 200. Only 10
(5%) of these 200 patients had ISCM. If one considers
the entire patient population, less than 1% of their can-
cer patients developed metastases to the spinal cord
[1,2]. This low incidence may be attributed to the fact
that the spinal cord is not a site that is examined fre-
quently during routine autopsy [3]. But in general, for
reasons unknown, the likelihood of malignant tumors
metastasizing to the cord intramedullary is low. Lung
cancer was found to be the most common source of
ISCM, accounting for 64% of the reported cases, fol-
lowed by breast cancer with 11%, melanoma 5%, renal
cell cancer 4%, colorectal cancer 3%, and lymphoma 3%;
the primary tumor remained unidentified in 5% of cases
[4-10].
Brown-Séquard syndrome is a rare syndrome and
most commonly described in conjunction with a
Figure 4 Sagittal T2-weighted MRI of his cervical spine shows an oblong expansile intramedullary lesion at the C2-C3 level of his
spinal cord, associated with large proximal and distal syrinx and edema extending from the cervico-medullary junction to the inferior
aspect of the T3 vertebral body.
Figure 5 Sagittal T1-weighted MRI of his cervical spine.
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caused by tumors. Brown-Séquard syndrome was found
in 23% of patients with ISCM [12-14]. This syndrome is
defined as an incomplete lesion of the spinal cord char-
acterized by ipsilateral upper motor neuron paralysis
and loss of proprioception, with contralateral loss of
pain and temperature sensation. A zone of partial pre-
servation or segmental ipsilateral lower motor neuron
weakness and analgesia may be noted. Loss of ipsilateral
autonomic function can result in Horner’s syndrome. As
an incomplete spinal cord syndrome, the clinical presen-
tation of Brown-Séquard syndrome may range from
mild to severe neurologic deficit [15,16]. Generally, it is
uncommon to find the full picture of Brown-Séquard
syndrome, hence it often being called incomplete or
partial.
There are two major features to differentiate clinically
between primary spinal tumors and ISCM. Acute pre-
sentation with rapidly worsening symptoms and the pre-
sence of metastases in other organs are typical of ISCM.
MRI is highly sensitive for detecting ISCM and demon-
strating the edema surrounding them [12]. PET has a
sensitivity of 96% in detecting spinal metastasis. This is
even more sensitive when combined with a CT scan
[17]. Radiotherapy is the gold-standard of therapy for
ISCM with long lasting remissions described in some
patients with lymphoma and small cell lung cancer
[18,19]. Steroids can be given to reduce edema, offering
clinical improvement without survival benefits.
Chemotherapy has failed to show any survival benefits,
as described in some limited studies [8,12]. Microsurgi-
cal resection is a treatment option but not appropriate
in most patients, who will often have other limiting co-
morbidities. Surgery is limited by the patient’sa g e ,p e r -
formance status, location and severity of the primary
neoplasm, presence of other metastases and biologic
characteristics of the tumor [12,13].
T h eo v e r a l lp r o g n o s i so fI S C Mi sp o o r ;m o r t a l i t yr a t e
is 80% during the first three to four months after the
appearance of the first symptom. The outcome is worse
with poorly differentiated tumors and those from lung
primaries [6,13,20].
Conclusion
Our patient had a rare diagnosis - an ISCM (a rare form
of metastatic disease) secondary to colonic carcinoma,
resulting in a presentation with a rare manifestation–
Brown-Séquard syndrome, which itself a very uncom-
mon condition. It is uncommon for this syndrome to be
caused by intramedullary tumors.
We hope that this report will add more information to
the literature about these entities.
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